Financial Ratios Max Healthcare Institute Limited
Equities
MAXHEALTH
INE027H01010
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 992.50 INR | -2.01% |
|
-2.11% | -5.01% |
| 12-30 | Indian Equities End Marginally Lower on Tuesday Amid Cautious Trading | MT |
| 12-19 | Indian Equities Rebound on Friday as Rupee Stability Lifts Sentiment | MT |
| Fiscal Period: March | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 2.43 | 5.31 | 6.64 | 7.21 | 7.02 | |||||
Return on Total Capital | 2.99 | 6.75 | 8.37 | 8.95 | 8.64 | |||||
Return On Equity % | -3.36 | 10.15 | 16.12 | 13.37 | 12.1 | |||||
Return on Common Equity | -3.36 | 10.15 | 16.12 | 13.37 | 12.1 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 50.86 | 55.54 | 60.52 | 62.03 | 62.28 | |||||
SG&A Margin | 22.55 | 22.2 | 23.43 | 20.66 | 20.98 | |||||
EBITDA Margin % | 15.53 | 23.95 | 26.8 | 27.41 | 26.05 | |||||
EBITA Margin % | 11.18 | 20.28 | 23.44 | 24.38 | 22.34 | |||||
EBIT Margin % | 9.69 | 19.15 | 22.44 | 23.59 | 21.73 | |||||
Income From Continuing Operations Margin % | -5.48 | 15.39 | 24.19 | 19.56 | 15.31 | |||||
Net Income Margin % | -5.48 | 15.39 | 24.19 | 19.56 | 15.31 | |||||
Net Avail. For Common Margin % | -5.48 | 15.39 | 24.19 | 19.56 | 15.31 | |||||
Normalized Net Income Margin | 3.75 | 12.14 | 14.71 | 16.09 | 13.48 | |||||
Levered Free Cash Flow Margin | 27.51 | 1.38 | 15.3 | 5.5 | 7.66 | |||||
Unlevered Free Cash Flow Margin | 31.77 | 2.82 | 16.28 | 6.02 | 8.98 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.4 | 0.44 | 0.47 | 0.49 | 0.52 | |||||
Fixed Assets Turnover | 2.4 | 2.05 | 2.13 | 1.83 | 1.4 | |||||
Receivables Turnover (Average Receivables) | 10.1 | 9.86 | 11.76 | 12.53 | 11.41 | |||||
Inventory Turnover (Average Inventory) | 30.58 | 30.36 | 26.19 | 26.31 | 28.5 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.45 | 1.32 | 1.86 | 1.37 | 0.88 | |||||
Quick Ratio | 1.31 | 1.18 | 1.57 | 1.19 | 0.78 | |||||
Operating Cash Flow to Current Liabilities | 0.15 | 0.99 | 1.16 | 0.9 | 0.8 | |||||
Days Sales Outstanding (Average Receivables) | 36.13 | 37.03 | 31.05 | 29.21 | 32 | |||||
Days Outstanding Inventory (Average Inventory) | 11.94 | 12.02 | 13.94 | 13.91 | 12.81 | |||||
Average Days Payable Outstanding | 89.16 | 92.29 | 99.23 | 108.64 | 98.22 | |||||
Cash Conversion Cycle (Average Days) | -41.1 | -43.23 | -54.24 | -65.52 | -53.41 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 19.53 | 14.54 | 9.3 | 15.45 | 32.09 | |||||
Total Debt / Total Capital | 16.34 | 12.69 | 8.51 | 13.38 | 24.29 | |||||
LT Debt/Equity | 17.96 | 12.73 | 8.16 | 14.13 | 29.5 | |||||
Long-Term Debt / Total Capital | 15.03 | 11.11 | 7.46 | 12.24 | 22.34 | |||||
Total Liabilities / Total Assets | 34.01 | 31.63 | 26.65 | 29.93 | 38.34 | |||||
EBIT / Interest Expense | 1.42 | 8.36 | 14.36 | 28.62 | 10.27 | |||||
EBITDA / Interest Expense | 2.4 | 10.74 | 17.52 | 33.96 | 12.64 | |||||
(EBITDA - Capex) / Interest Expense | 1.71 | 4.5 | 12.81 | 16.32 | 6.14 | |||||
Total Debt / EBITDA | 2.69 | 0.94 | 0.55 | 0.86 | 1.6 | |||||
Net Debt / EBITDA | 1.16 | 0.45 | -0.47 | 0.21 | 1.25 | |||||
Total Debt / (EBITDA - Capex) | 3.78 | 2.25 | 0.75 | 1.79 | 3.29 | |||||
Net Debt / (EBITDA - Capex) | 1.63 | 1.07 | -0.64 | 0.44 | 2.57 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 136.82 | 56.76 | 15.9 | 18.49 | 30.01 | |||||
Gross Profit, 1 Yr. Growth % | 116.15 | 71.18 | 26.16 | 18.43 | 30.55 | |||||
EBITDA, 1 Yr. Growth % | 345.76 | 141.67 | 29.16 | 21.21 | 23.57 | |||||
EBITA, 1 Yr. Growth % | 421.82 | 184.48 | 33.24 | 23.25 | 19.17 | |||||
EBIT, 1 Yr. Growth % | 404.04 | 209.76 | 35.1 | 24.54 | 19.78 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -333.18 | -539.88 | 82.38 | -4.16 | 1.72 | |||||
Net Income, 1 Yr. Growth % | -333.18 | -539.88 | 82.38 | -4.16 | 1.72 | |||||
Normalized Net Income, 1 Yr. Growth % | 184.22 | 407.77 | 40.62 | 29.61 | 8.94 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -257.79 | -491.59 | 82.05 | -4.58 | 1.57 | |||||
Accounts Receivable, 1 Yr. Growth % | 258.97 | 5.71 | -10.65 | 35.59 | 48.13 | |||||
Inventory, 1 Yr. Growth % | 100.75 | 14.05 | 24.23 | 4.74 | 33.03 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 457.59 | 15.97 | 8.13 | 65.84 | 72.37 | |||||
Total Assets, 1 Yr. Growth % | 115.03 | 7.55 | 9.93 | 18.79 | 26.79 | |||||
Tangible Book Value, 1 Yr. Growth % | -57.34 | 37.85 | 99.99 | 20.54 | 18.41 | |||||
Common Equity, 1 Yr. Growth % | 120.85 | 11.42 | 17.94 | 13.48 | 11.57 | |||||
Cash From Operations, 1 Yr. Growth % | 52.89 | 535.07 | 63.29 | -12.64 | 30.1 | |||||
Capital Expenditures, 1 Yr. Growth % | 31.45 | 374 | -39.35 | 134.19 | 22.85 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -167.85 | -92.11 | 964.68 | -62.57 | 81.03 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -182.32 | -86.11 | 509.62 | -61.24 | 94.11 | |||||
Dividend Per Share, 1 Yr. Growth % | - | - | - | 50 | 0 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 21.68 | 92.67 | 34.88 | 17.19 | 24.11 | |||||
Gross Profit, 2 Yr. CAGR % | 22.43 | 92.35 | 47.13 | 23.78 | 24.34 | |||||
EBITDA, 2 Yr. CAGR % | 59.94 | 228.22 | 77.16 | 25.12 | 22.39 | |||||
EBITA, 2 Yr. CAGR % | 99.9 | 285.29 | 95.31 | 28.15 | 21.19 | |||||
EBIT, 2 Yr. CAGR % | 106.66 | 295.14 | 105.26 | 29.71 | 22.14 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 2.59K | 220.26 | 183.24 | 32.21 | -1.26 | |||||
Net Income, 2 Yr. CAGR % | 576 | 220.26 | 183.24 | 32.21 | -1.26 | |||||
Normalized Net Income, 2 Yr. CAGR % | 466.31 | 279.89 | 167.21 | 35 | 18.83 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 415.35 | 148.58 | 167 | 31.8 | -1.55 | |||||
Accounts Receivable, 2 Yr. CAGR % | 1.8 | 94.8 | -2.81 | 10.07 | 41.72 | |||||
Inventory, 2 Yr. CAGR % | 43.82 | 51.31 | 19.03 | 14.07 | 18.04 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 31.64 | 154.29 | 11.98 | 33.91 | 69.08 | |||||
Total Assets, 2 Yr. CAGR % | 59.33 | 52.07 | 8.73 | 14.28 | 22.72 | |||||
Tangible Book Value, 2 Yr. CAGR % | 70.63 | -23.31 | 66.04 | 55.26 | 19.47 | |||||
Common Equity, 2 Yr. CAGR % | 141.95 | 56.87 | 14.63 | 15.69 | 12.52 | |||||
Cash From Operations, 2 Yr. CAGR % | 15.11 | 211.6 | 220.3 | 23.08 | 6.6 | |||||
Capital Expenditures, 2 Yr. CAGR % | 1.16 | 149.61 | 68.35 | 19.18 | 69.62 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 4.91 | -76.87 | 0.58 | 112.98 | -17.68 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 7.7 | -66.19 | -3.46 | 63.4 | -13.26 | |||||
Dividend Per Share, 2 Yr. CAGR % | - | - | - | - | 22.47 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 13.17 | 32.4 | 62.72 | 29.18 | 21.32 | |||||
Gross Profit, 3 Yr. CAGR % | 15.79 | 36.9 | 67.26 | 38.01 | 26 | |||||
EBITDA, 3 Yr. CAGR % | 49.77 | 83.53 | 140.96 | 56.11 | 24.6 | |||||
EBITA, 3 Yr. CAGR % | 88.77 | 124.85 | 171.01 | 67.52 | 25.08 | |||||
EBIT, 3 Yr. CAGR % | 124.29 | 136.51 | 176.92 | 73.77 | 26.31 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 68.54 | 1.37K | 165.46 | 97.38 | 21.15 | |||||
Net Income, 3 Yr. CAGR % | 87.76 | 485.79 | 165.46 | 97.38 | 21.15 | |||||
Normalized Net Income, 3 Yr. CAGR % | 73.82 | 446.09 | 172.76 | 109.95 | 25.69 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 41.59 | 370.27 | 124.06 | 89.48 | 20.84 | |||||
Accounts Receivable, 3 Yr. CAGR % | 13.02 | 3.08 | 50.23 | 8.6 | 21.52 | |||||
Inventory, 3 Yr. CAGR % | 23.92 | 33.12 | 41.69 | 14.06 | 20.07 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 21.24 | 26.2 | 91.22 | 27.64 | 45.67 | |||||
Total Assets, 3 Yr. CAGR % | 37.02 | 39.77 | 36.48 | 11.99 | 18.3 | |||||
Tangible Book Value, 3 Yr. CAGR % | 53.4 | 58.92 | 5.56 | 49.23 | 41.85 | |||||
Common Equity, 3 Yr. CAGR % | 76.02 | 86.84 | 42.64 | 14.25 | 14.3 | |||||
Cash From Operations, 3 Yr. CAGR % | 12.75 | 103.4 | 150.32 | 111.93 | 25.37 | |||||
Capital Expenditures, 3 Yr. CAGR % | 21.8 | 69.27 | 55.02 | 87.93 | 20.39 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 166.67 | -55.72 | -11.79 | -24.46 | 101.75 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 237.59 | -45.59 | -8.46 | -25.82 | 73.06 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.82 | 19.57 | 21.4 | 26.12 | 46.01 | |||||
Gross Profit, 5 Yr. CAGR % | 12.74 | 22.33 | 27.43 | 31.55 | 49.3 | |||||
EBITDA, 5 Yr. CAGR % | 31.8 | 46.17 | 60.17 | 57.63 | 83.76 | |||||
EBITA, 5 Yr. CAGR % | 72.66 | 64.75 | 91.36 | 79.79 | 96.42 | |||||
EBIT, 5 Yr. CAGR % | 80.18 | 75.21 | 116.48 | 86.25 | 99.6 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 43.49 | 236.61 | 107.44 | 461.2 | 78.73 | |||||
Net Income, 5 Yr. CAGR % | 43.49 | 107.34 | 121.32 | 222.96 | 78.73 | |||||
Normalized Net Income, 5 Yr. CAGR % | 47.52 | 129.85 | 106.44 | 212.24 | 95.63 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 34.65 | 190.81 | 82.48 | 182.73 | 61.25 | |||||
Accounts Receivable, 5 Yr. CAGR % | 11.97 | 10.79 | 6.4 | 5.82 | 46.77 | |||||
Inventory, 5 Yr. CAGR % | 18.3 | 21.56 | 21.94 | 25.15 | 31.71 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 12.63 | 15.38 | 17.45 | 29.23 | 82.03 | |||||
Total Assets, 5 Yr. CAGR % | 22.92 | 23.8 | 24.92 | 28.95 | 30.8 | |||||
Tangible Book Value, 5 Yr. CAGR % | 36.85 | 50.4 | 58.33 | 57.45 | 10.92 | |||||
Common Equity, 5 Yr. CAGR % | 37.96 | 41.21 | 48.27 | 54.24 | 29.73 | |||||
Cash From Operations, 5 Yr. CAGR % | -30.42 | 36.83 | 71.2 | 66.02 | 80.07 | |||||
Capital Expenditures, 5 Yr. CAGR % | -40.63 | 37.3 | 38.63 | 46.69 | 60.7 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | -14.55 | -10.45 | 80.55 | -13.85 | -11.94 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | -11.57 | 25.98 | 104.6 | -13.89 | -8.19 |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















